Global Point of Care
Global Point of Care
Managing workload and timeliness in critical care units depends on the ability of its personnel and processes to be efficient, effective, and accurate. Errors including failure to carry out accurate treatment in critical patients can result in preventable disability and/or death.1 Patient safety is directly affected by the impacts of overwhelming workload among critical care personnel. A safe care environment may be compromised when critical care nurses experience high workload stressors.2 As State and Federal Agencies issue regulations related to mandatory overtime and clinical process measures, evidence is mounting regarding the impact of workload on patient outcomes and errors.
Accurate and timely diagnoses may mean replacing more invasive devices with less invasive devices, thus decreasing the likelihood of complications, including infection.3 This has long been recommended by many clinical intensivist organizations from around the world as a means to improve patient safety and quality outcomes. This is especially true for cardiac conditions in critical and intensive care patients.3
Using point-of-care (POC) diagnostics may improve workload by moving testing from a centralized lab to the bedside, improving diagnosis-to-treatment time and decreasing preanalytical errors.4 This can have positive outcomes, including reducing patient blood draws, decreasing the use of blood volume needed for testing, and faster diagnostic results, allowing for the development of accurate treatment protocols. Another positive outcome using POC diagnostics may be the reduction of potential errors from patient identification that can occur when tests are sent to a centralized lab.5 Performing testing at the bedside reduces patient identification errors.5 These factors alone can have a potential impact on decreasing an overwhelming workload and improving patient safety.
“At one health care facility, POC bedside testing has resulted in a 44% reduction in length of stay.6 ”
At one health care facility, POC bedside testing has resulted in a 44% reduction in length of stay which decreases the risk of adverse events such as healthcare associated infections (HAIs) and other extended stay complications.6 Facility financial health may also improve as POC testing has been shown to decrease patient care costs in one hospital by 47%.6
Federal and state governments, as well as accreditation and quality organizations continue to create more measures focused on patient outcome, care coordination, and staffing in an effort to improve quality and safety, control costs, and increase accountability. These measures have an impact not only on reimbursement and fiscal health, but also on a facility’s ability to market itself as a viable and safe treatment facility to its communities.
* The results shown here are specific to this health care facility and may differ from those achieved by other institutions.
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.